SUBSCRIBE
SUBSCRIBE

Abbott Laboratories’ Kaletra HIV-Drug Patent Rejected in India, Allowing Cipla Ltd. Copies

January 4, 2011 | 
1 min read
Bloomberg -- Abbott Laboratories was refused copyright protection on its AIDS drug Kaletra by India’s patent office, allowing Cipla Ltd. and other generic-drug companies to continue selling copies.
Asia
Abbott Laboratories
MORE ON THIS TOPIC
Roche's tower in Shanghai, China
Manufacturing
Roche makes $300M China Production Promise After Multibillion US Investment
May 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Workplace conflict Job rivalry, jealousy among colleagues concept, angry coworker fighting by pulling golden crown metaphor of job promotion position.
Cancer
Summit’s Campaign To Conquer Keytruda Nears First Global Phase III Data
May 7, 2025
 · 
5 min read
 · 
Nick Paul Taylor
Podcast
Tariffs Continue to Dominate Q1 Earnings, AACR Excites Cancer Space, CEO Pay Gaps, More
April 30, 2025
 · 
1 min read
 · 
Heather McKenzie
Chess made from China and EU, USA flags. Europe Union, USA and China relations
Tariffs
China Still Go-To Source for New Drugs Despite Tariff Minefield
April 30, 2025
 · 
10 min read
 · 
Annalee Armstrong